← All Sponsors
SPONSOR

BlueRock Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Parkinsons Disease (PD)
NCT06944522 Phase 3
Recruiting

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Parkinsons Disease (PD)
United States, Australia, Canada View Trial →